Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b1357cafbc03921a13589c41dd1e9860 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-686 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-705 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70 |
filingDate |
2013-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2756ce50be814f950ffa587cbcb77e29 |
publicationDate |
2015-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2014025254-A9 |
titleOfInvention |
Ebv markers and systemic lupus erythematosus |
abstract |
The present invention relates to an in vitro method for diagnosis and/or determining severity of Systemic Lupus Erythematosus. The method determines presence and/or quantity of at least one EBV marker, preferably EBV-EBER and/or antibody against EBV antigen, in a sample obtained from a subject. The method may further be used to discriminate between Systemic Lupus Erythematosus, and rheumatoid arthritis. |
priorityDate |
2012-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |